Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate Cancer

Phase 2

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

CompletedNCT00108732

National Cancer Institute (NCI)Recurrent Prostate Carcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer +2

Start: 2006-02-28End: 2010-10-31Updated: 2015-06-30

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

TerminatedNCT01145508

National Cancer Institute (NCI)Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma +1

Start: 2010-08-31End: 2015-10-31Updated: 2017-09-19